NASDAQ: INMB - INmune Bio, Inc.

Lønnsomhet i seks måneder: -42.38%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan INmune Bio, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet INmune Bio, Inc.

INmune Bio, Inc., a clinical-stage immunology company, focuses on reprogramming the patient's innate immune system to treat cancer and neurodegenerative diseases. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation.

flere detaljer
The company's development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma solid tumor and patients with high-risk myelodysplastic syndrome; INB03 to treat patients with cancers that express MUC4, a mucinous polyglucan on the surface of some epithelial cancer cells that appears to predict resistant to immunotherapy, including women with MUC4 expressing HER2+ breast cancer and other MUC4 resistant cancers; and XPro1595 for the treatment of Alzheimer's disease and Treatment Resistant Depression. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. The company was incorporated in 2015 and is headquartered in Boca Raton, Florida.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2019-02-04
ISIN US45782T1051
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.inmunebio.com
Цена ао 11.88
Prisendring per dag: -1.69% (4.73)
Prisendring per uke: +5.68% (4.4)
Prisendring per måned: -4.91% (4.89)
Prisendring over 3 måneder: -10.92% (5.22)
Prisendring over seks måneder: -42.38% (8.07)
Prisendring per år: -58.7% (11.26)
Prisendring over 3 år: -56.38% (10.66)
Prisendring over 5 år: +15.38% (4.03)
Prisendring over 10 år: 0% (4.65)
Prisendring siden begynnelsen av året: -4.71% (4.88)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 1220.37 1
P/BV 4.96 3
P/E 0 0
EV/EBITDA -5.51 0
Total: 2.63

Effektivitet

Navn Betydning Karakter
ROA, % -52.64 0
ROE, % -78.68 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.3509 10
Total: 9.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -99.8 0
Lønnsomhet Ebitda, % 175.38 10
Lønnsomhet EPS, % 87.52 9
Total: 7.8
Flere detaljer

Institusjoner Volum Dele, %
Vanguard Group Inc 541329 3
Blackrock Inc. 257929 1.43
Rhenman & Partners Asset Management AB 178284 0.99
Geode Capital Management, LLC 170040 0.94
Janney Montgomery Scott LLC 163559 0.91
Deutsche Bank Aktiengesellschaft 109848 0.61
MAI Capital Management 98012 0.54
Quadrant Capital Group LLC 60000 0.33
Royal Bank of Canada 57791 0.32
State Street Corporation 45063 0.25

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Micro-Cap ETF 0.01798 17.09 1.54048
Vanguard Russell 2000 Growth ETF 0.01 23.05 0.60264
iShares Russell 2000 Growth ETF 0.0057 38.04 0.6026
ProShares UltraPro Russell2000 0.00138 89.82 1.47873
ProShares Hedge Replication ETF 0.00039 5.92 1.47892
Avantis U.S Small Cap Equity ETF 0.00028 27.77 1.68271
Vanguard Russell 3000 ETF 0 31.87 1.43817
Vanguard Russell 2000 ETF 0 17.16 1.48801



Veileder Stillingstittel Betaling Fødselsår
Dr. Raymond Joseph Tesi M.D. Co-Founder, President, CEO, Chief Medical Officer & Chairman 500.5k 1956 (69 år)
Mr. David J. Moss M.B.A. CFO, Treasurer & Secretary 394.9k 1970 (55 år)
Dr. Mark William Lowdell BSc, FRCPath, MICR, MSc, Ph.D. Chief Scientific Officer & Chief Manufacturing Officer 150.24k 1963 (62 år)
Mr. Joshua S. Schoonover Esq. General Counsel N/A

Adresse: United States, Boca Raton. FL, 225 NE Mizner Blvd. - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.inmunebio.com